{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"68"},{"groupId":"OG001","value":"63"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"91"},{"groupId":"OG001","value":"91"}],"units":"Participants"}],"description":"Percentage of patients with Severe Oral Mucositis (WHO Grade 3 or 4) per arm.","groups":[{"description":"Patients rinse and gargle with placebo over 1 minute QID beginning the first day (about day -7) of the conditioning regimen. Treatment continues until day 20 post-transplantation.\n\nplacebo: Mouth rinse\n\nquestionnaire administration: Ancillary studies\n\nquality-of-life assessment: Ancillary studies","id":"OG000","title":"Arm I (Placebo)"},{"description":"Patients rinse and gargle with supersaturated calcium phosphate rinse over 1 minute QID beginning on the first day (about day -7) of the conditioning regimen. Treatment continues until day 20 post-transplantation.\n\nsupersaturated calcium phosphate rinse: Mouth rinse\n\nquestionnaire administration: Ancillary studies\n\nquality-of-life assessment: Ancillary studies","id":"OG001","title":"Arm II (Supersaturated Calcium Phosphate Rinse)"}],"paramType":"NUMBER","populationDescription":"Evaluable patients defined as patients with \\>= 11 daily WHO assessments.","reportingStatus":"POSTED","timeFrame":"Day -1 (day prior to stem cell infusion) to Day 20 following transplantation.","title":"Incidence of Severe Oral Mucositis","type":"SECONDARY","unitOfMeasure":"percent of patients"}